Brown Brothers Harriman & Co’s Gentex GNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-46
Closed -$1K 1852
2026
Q1
$1K Hold
46
﹤0.01% 1740
2025
Q4
$1.07K Hold
46
﹤0.01% 1781
2025
Q3
$1.3K Hold
46
﹤0.01% 1615
2025
Q2
$1.01K Buy
+46
New +$1.01K ﹤0.01% 1491
2023
Q1
Sell
-2,400
Closed -$65.4K 1293
2022
Q4
$65.4K Hold
2,400
﹤0.01% 671
2022
Q3
$57K Sell
2,400
-510
-18% -$14K ﹤0.01% 709
2022
Q2
$81K Buy
2,910
+510
+21% +$14.8K ﹤0.01% 616
2022
Q1
$70K Hold
2,400
﹤0.01% 702
2021
Q4
$84K Buy
+2,400
New +$85.2K ﹤0.01% 617
2020
Q1
Sell
-26
Closed -$1K 1171
2019
Q4
$1K Hold
26
﹤0.01% 1069
2019
Q3
$1K Hold
26
﹤0.01% 1121
2019
Q2
$1K Buy
+26
New +$589 ﹤0.01% 1017
2019
Q1
Sell
-429
Closed -$9K 1040
2018
Q4
$9K Buy
429
+105
+32% +$2.2K ﹤0.01% 701
2018
Q3
$7K Buy
324
+214
+195% +$4.95K ﹤0.01% 720
2018
Q2
$3K Hold
110
﹤0.01% 759
2018
Q1
$3K Sell
110
-270
-71% -$6.14K ﹤0.01% 726
2017
Q4
$8K Buy
+380
New +$7.56K ﹤0.01% 783
2015
Q4
Sell
-1,000
Closed -$16K 764
2015
Q3
$16K Buy
+1,000
New +$15.9K ﹤0.01% 638
2013
Q3
Sell
-4,000
Closed -$46K 733
2013
Q2
$46K Buy
+4,000
New +$45.1K ﹤0.01% 544

Other funds holding GNTX

Brown Brothers Harriman & Co's GNTX Position: Q2 2026 in Review

Brown Brothers Harriman & Co sold out of Gentex (GNTX) in Q2 2026, closing a stake of 46 shares — an estimated $1K sold.

Brown Brothers Harriman & Co first reported a position in GNTX in Q2 2013 and held it in 19 quarters. The position peaked at $84K in Q4 2021. 531 funds tracked by Wall St. Rank hold GNTX as of Q2 2026.

  • Brown Brothers Harriman & Co reported no remaining Gentex position as of Q2 2026 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 46 Gentex shares in Q2 2026, an estimated $1K.
  • Brown Brothers Harriman & Co first reported a position in Gentex in Q2 2013 and held it in 19 quarters.
  • Brown Brothers Harriman & Co's Gentex position peaked at $84K in Q4 2021.
  • 531 funds tracked by Wall St. Rank held Gentex as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.